Correction to: Efficacy of Ronopterin (VAS203) in Patients with Moderate and Severe Traumatic Brain Injury (NOSTRA phase III trial): study protocol of a confirmatory, placebo-controlled, randomised, double blind, multi-centre study
Traumatic brain injury is a leading cause of death and disability worldwide. The nitric oxide synthase inhibitor Ronopterin was shown to improve clinical outcome by enhancing neuroprotection in a phase IIa trial.
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
12 February 2020
|
| In: |
Trials
Year: 2020, Volume: 21, Pages: 1 |
| ISSN: | 1468-6694 |
| DOI: | 10.1186/s13063-020-4107-8 |
| Online Access: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1186/s13063-020-4107-8 |
| Author Notes: | Frank Tegtmeier, Reinhard Schinzel, Ronny Beer, Diederik Bulters, Jean-Yves LeFrant, Joan Sahuquillo, Andreas Unterberg, Peter Andrews, Antonio Belli, Javier Ibanez, Alfonso Lagares, Michael Mokry, Harald Willschke, Charlotte Flüh, Erich Schmutzhard and on behalf of the NOSTRA Investigators |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 169382616X | ||
| 003 | DE-627 | ||
| 005 | 20220818030415.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 200402s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1186/s13063-020-4107-8 |2 doi | |
| 035 | |a (DE-627)169382616X | ||
| 035 | |a (DE-599)KXP169382616X | ||
| 035 | |a (OCoLC)1341313516 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Tegtmeier, Frank |e VerfasserIn |0 (DE-588)1207493155 |0 (DE-627)1693824086 |4 aut | |
| 245 | 1 | 0 | |a Correction to: Efficacy of Ronopterin (VAS203) in Patients with Moderate and Severe Traumatic Brain Injury (NOSTRA phase III trial) |b study protocol of a confirmatory, placebo-controlled, randomised, double blind, multi-centre study |c Frank Tegtmeier, Reinhard Schinzel, Ronny Beer, Diederik Bulters, Jean-Yves LeFrant, Joan Sahuquillo, Andreas Unterberg, Peter Andrews, Antonio Belli, Javier Ibanez, Alfonso Lagares, Michael Mokry, Harald Willschke, Charlotte Flüh, Erich Schmutzhard and on behalf of the NOSTRA Investigators |
| 264 | 1 | |c 12 February 2020 | |
| 300 | |a 1 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 02.04.2020 | ||
| 520 | |a Traumatic brain injury is a leading cause of death and disability worldwide. The nitric oxide synthase inhibitor Ronopterin was shown to improve clinical outcome by enhancing neuroprotection in a phase IIa trial. | ||
| 700 | 1 | |a Unterberg, Andreas |e VerfasserIn |0 (DE-588)1032681187 |0 (DE-627)738641200 |0 (DE-576)168441233 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Trials |d London : BioMed Central, 2000 |g 21(2020), Artikel-ID 172, Seite 1 |h Online-Ressource |w (DE-627)326173552 |w (DE-600)2040523-6 |w (DE-576)107014556 |x 1468-6694 |7 nnas |a Correction to: Efficacy of Ronopterin (VAS203) in Patients with Moderate and Severe Traumatic Brain Injury (NOSTRA phase III trial) study protocol of a confirmatory, placebo-controlled, randomised, double blind, multi-centre study |
| 773 | 1 | 8 | |g volume:21 |g year:2020 |g elocationid:172 |g pages:1 |g extent:1 |a Correction to: Efficacy of Ronopterin (VAS203) in Patients with Moderate and Severe Traumatic Brain Injury (NOSTRA phase III trial) study protocol of a confirmatory, placebo-controlled, randomised, double blind, multi-centre study |
| 787 | 0 | 8 | |i Errata zu |a Tegtmeier, Frank |t Efficacy of Ronopterin (VAS203) in Patients with Moderate and Severe Traumatic Brain Injury (NOSTRA phase III trial) |d 2020 |w (DE-627)1693824558 |
| 856 | 4 | 0 | |u https://doi.org/10.1186/s13063-020-4107-8 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20210518 | ||
| 993 | |a Article | ||
| 994 | |a 2020 | ||
| 998 | |g 1032681187 |a Unterberg, Andreas |m 1032681187:Unterberg, Andreas |d 910000 |d 911200 |e 910000PU1032681187 |e 911200PU1032681187 |k 0/910000/ |k 1/910000/911200/ |p 7 | ||
| 999 | |a KXP-PPN169382616X |e 3929367521 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"type":{"media":"Online-Ressource","bibl":"article-journal"},"language":["eng"],"relHost":[{"origin":[{"publisherPlace":"London","publisher":"BioMed Central","dateIssuedKey":"2000","dateIssuedDisp":"2000-"}],"titleAlt":[{"title":"Current controlled trials in cardiovascular medicine"}],"physDesc":[{"extent":"Online-Ressource"}],"disp":"Correction to: Efficacy of Ronopterin (VAS203) in Patients with Moderate and Severe Traumatic Brain Injury (NOSTRA phase III trial) study protocol of a confirmatory, placebo-controlled, randomised, double blind, multi-centre studyTrials","id":{"issn":["1468-6694","1745-6215"],"zdb":["2040523-6"],"eki":["326173552"]},"note":["Gesehen am 26.09.22"],"title":[{"title_sort":"Trials","title":"Trials"}],"pubHistory":["1.2000 -"],"language":["eng"],"type":{"bibl":"periodical","media":"Online-Ressource"},"recId":"326173552","part":{"extent":"1","text":"21(2020), Artikel-ID 172, Seite 1","volume":"21","pages":"1","year":"2020"}}],"recId":"169382616X","name":{"displayForm":["Frank Tegtmeier, Reinhard Schinzel, Ronny Beer, Diederik Bulters, Jean-Yves LeFrant, Joan Sahuquillo, Andreas Unterberg, Peter Andrews, Antonio Belli, Javier Ibanez, Alfonso Lagares, Michael Mokry, Harald Willschke, Charlotte Flüh, Erich Schmutzhard and on behalf of the NOSTRA Investigators"]},"physDesc":[{"extent":"1 S."}],"origin":[{"dateIssuedKey":"2020","dateIssuedDisp":"12 February 2020"}],"person":[{"family":"Tegtmeier","display":"Tegtmeier, Frank","given":"Frank","role":"aut"},{"family":"Unterberg","display":"Unterberg, Andreas","role":"aut","given":"Andreas"}],"id":{"doi":["10.1186/s13063-020-4107-8"],"eki":["169382616X"]},"title":[{"title":"Correction to: Efficacy of Ronopterin (VAS203) in Patients with Moderate and Severe Traumatic Brain Injury (NOSTRA phase III trial)","title_sort":"Correction to: Efficacy of Ronopterin (VAS203) in Patients with Moderate and Severe Traumatic Brain Injury (NOSTRA phase III trial)","subtitle":"study protocol of a confirmatory, placebo-controlled, randomised, double blind, multi-centre study"}],"note":["Gesehen am 02.04.2020"]} | ||
| SRT | |a TEGTMEIERFCORRECTION1220 | ||